Torgano G et al. |
Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. |
1999 |
Circulation |
pmid:10096930
|
Navuluri R and Yue S |
Understanding peptic ulcer disease pharmacotherapeutics. |
1999 |
Nurse Pract |
pmid:10100245
|
Fournier S et al. |
Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10192709
|
Gómez-Gil E et al. |
Clarithromycin-induced acute psychoses in peptic ulcer disease. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10192720
|
Lee CK et al. |
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. |
1999 |
Vaccine |
pmid:10195786
|
Bartnof HS |
OIs and cancers. |
1999 |
BETA |
pmid:11367262
|
Gimenez Garcia R et al. |
Fish tank granuloma: response to treatment with clarithromycin. |
1999 |
J Eur Acad Dermatol Venereol |
pmid:10188167
|
Dubé MP et al. |
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group. |
1999 |
Clin. Infect. Dis. |
pmid:10028084
|
Moreau P et al. |
Lack of efficacy of clarithromycin in advanced multiple myeloma. Intergroupe Français du Myélome (IFM) |
1999 |
Leukemia |
pmid:10086745
|
Unge P |
Antibiotic treatment of Helicobacter pylori infection. |
1999 |
Curr. Top. Microbiol. Immunol. |
pmid:10087665
|
Wreiber K et al. |
[Development of resistant Helicobacter pylori in Sweden. Tendency toward increasing resistance to clarithromycin]. |
1999 |
Lakartidningen |
pmid:10087796
|
Sakatani M |
[Multi-drug resistant mycobacterial infection]. |
1999 |
Ryoikibetsu Shokogun Shirizu |
pmid:10088372
|
GarcÃa-Romero E et al. |
[Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer]. |
1999 |
Gastroenterol Hepatol |
pmid:10089703
|
Shirtliff ME et al. |
Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits. |
1999 |
Clin. Orthop. Relat. Res. |
pmid:10078148
|
Ong EL |
Prophylaxis against disseminated Mycobacterium avium complex in AIDS. |
1999 |
J. Infect. |
pmid:10090497
|
Uygun A et al. |
Low efficacy of ranitidine bismuth citrate plus clarithromycin combination on Helicobacter pylori in a Turkish population. |
1999 |
Am. J. Gastroenterol. |
pmid:10520880
|
Gibson JR et al. |
Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori. |
1999 |
J. Clin. Microbiol. |
pmid:10523591
|
Osato MS et al. |
Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10493611
|
Hirsh DC and Jang SS |
Antimicrobial susceptibility of Nocardia nova isolated from five cats with nocardiosis. |
1999 |
J. Am. Vet. Med. Assoc. |
pmid:10496134
|
Dani R et al. |
Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594400
|
Ellenrieder V et al. |
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. |
1999 |
Scand. J. Gastroenterol. |
pmid:10499474
|
Harris A |
The importance of clarithromycin dose in the management of H. pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594406
|
Gomollón F et al. |
Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases. |
1999 |
Helicobacter |
pmid:10597390
|
Landesman KA et al. |
Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics. |
1999 |
Conn Med |
pmid:10500341
|
Auclair B et al. |
Potential interaction between itraconazole and clarithromycin. |
1999 |
Pharmacotherapy |
pmid:10600094
|
Unge P |
The OAC and OMC options. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503817
|
Feldman M et al. |
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. |
1999 |
Am. J. Physiol. |
pmid:10600812
|
Spiller RC |
Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia? |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503819
|
Mégraud F |
Resistance of Helicobacter pylori to antibiotics: the main limitation of current proton-pump inhibitor triple therapy. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503821
|
Sainz R et al. |
[Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group]. |
1999 |
Rev Esp Enferm Dig |
pmid:10601771
|
Bazzoli F et al. |
What can be learnt from the new data about antibiotic resistance? Are there any practical clinical consequences of Helicobacter pylori antibiotic resistance? |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503822
|
Gisbert JP et al. |
Re-treatment after Helicobacter pylori eradication failure. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503846
|
Geiderman JM |
Central nervous system disturbances following clarithromycin ingestion. |
1999 |
Clin. Infect. Dis. |
pmid:10476775
|
Gómez Cubillos C et al. |
[Can macrolide treatment delay the diagnosis of tuberculosis?]. |
1999 |
An Med Interna |
pmid:10481348
|
Kohyama T et al. |
Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10103198
|
Lugannani C and Strickland C |
Empiric eradication therapy or endoscopy in Helicobacter pylori-positive patients? |
1999 |
J Fam Pract |
pmid:10628582
|
GarcÃa-Arata MI et al. |
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin. |
1999 |
Antimicrob. Agents Chemother. |
pmid:9925537
|
Blondon H |
[Eradication of Helicobacter pylori: what is the effect on symptoms of non-ulcerous dyspepsia?]. |
1999 |
Presse Med |
pmid:10629694
|
Uygun A et al. |
Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population. |
1999 |
Clin Ther |
pmid:10509849
|
Cammarota G et al. |
Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection. |
1999 |
Dig. Dis. Sci. |
pmid:10630486
|
Bortolotti M et al. |
Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis. |
1999 |
Dig. Dis. Sci. |
pmid:10630494
|
Furuta T et al. |
Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans. |
1999 |
Clin. Pharmacol. Ther. |
pmid:10511062
|
Sharma VK et al. |
A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection. |
1999 |
Am. J. Gastroenterol. |
pmid:10566709
|
Fattorini L et al. |
Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice. |
1999 |
Microb. Drug Resist. |
pmid:10566874
|
Juurlink DN and Ito S |
Comment: clarithromycin-digoxin interaction. |
1999 |
Ann Pharmacother |
pmid:10630847
|
Talley NJ et al. |
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. |
1999 |
N. Engl. J. Med. |
pmid:10511608
|
Lamouliatte H et al. |
Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10571611
|
Baylor P and Williams K |
Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy. |
1999 |
Clin. Infect. Dis. |
pmid:10525003
|
Stengel W |
[Sporotrichoid mycobacteriosis caused by Mycobacterium marinum]. |
1999 |
Dtsch. Med. Wochenschr. |
pmid:10572519
|
Madsen LG et al. |
Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy. |
1999 |
Dig. Dis. Sci. |
pmid:10573379
|
Furusyo N et al. |
Rapidly growing primary gastric B-cell lymphoma after eradication of Helicobacter pylori. |
1999 |
Intern. Med. |
pmid:10526942
|
Semret M et al. |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. |
1999 |
Am. J. Trop. Med. Hyg. |
pmid:10586895
|
Chérin P et al. |
Macrophagic myofasciitis: improvement with antibiotic therapy. |
1999 |
J. Rheumatol. |
pmid:10529163
|
Nasu T et al. |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains]. |
1999 |
Jpn J Antibiot |
pmid:10587879
|
Moola S et al. |
A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia. |
1999 |
Chest |
pmid:10531162
|
Langan CE et al. |
Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis. |
1999 |
J. Antimicrob. Chemother. |
pmid:10588313
|
Unal M et al. |
Ocular toxicity of intravitreal clarithromycin. |
1999 |
Retina (Philadelphia, Pa.) |
pmid:10546942
|
Rodvold KA |
Clinical pharmacokinetics of clarithromycin. |
1999 |
Clin Pharmacokinet |
pmid:10589373
|
Woo PC et al. |
Antibiotics modulate vaccine-induced humoral immune response. |
1999 |
Clin. Diagn. Lab. Immunol. |
pmid:10548572
|
Adamsson I et al. |
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. |
1999 |
J. Antimicrob. Chemother. |
pmid:10552979
|
Cirioni O et al. |
In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. |
1999 |
J. Antimicrob. Chemother. |
pmid:10552982
|
Blackington E |
The gastric demon. An update on Helicobacter pylori infection. |
1999 |
Adv Nurse Pract |
pmid:10745720
|
Sieg A et al. |
Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383519
|
Grimley CE et al. |
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383520
|
Houben MH et al. |
Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383522
|
Tomiyama Y et al. |
[The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection]. |
1999 |
Kekkaku |
pmid:10386036
|
Katsura Y et al. |
Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles. |
1999 |
J. Med. Chem. |
pmid:10425101
|
Marini RP et al. |
Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets. |
1999 |
Am. J. Vet. Res. |
pmid:10791942
|
Williams SL et al. |
Development of a firefly luciferase-based assay for determining antimicrobial susceptibility of Mycobacterium avium subsp. paratuberculosis. |
1999 |
J. Clin. Microbiol. |
pmid:9889208
|
Grimm KJ |
Treatment of Helicobacter pylori infection in functional dyspepsia. |
1999 |
J Fam Pract |
pmid:10428242
|
Savarino V et al. |
Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:9892878
|
Gooch WM et al. |
Loracarbef versus clarithromycin in children with acute otitis media with effusion. |
1999 |
Clin Ther |
pmid:10363736
|
Moshkowitz M et al. |
The efficacy of omeprazole-based short-term triple therapy in Helicobacter pylori-positive older patients with dyspepsia. |
1999 |
J Am Geriatr Soc |
pmid:10366173
|
Wimsatt JH et al. |
Clarithromycin pharmacokinetics in the desert tortoise (Gopherus agassizii). |
1999 |
J. Zoo Wildl. Med. |
pmid:10367642
|
Iida H et al. |
Hypoglycemia induced by interaction between clarithromycin and disopyramide. |
1999 |
Jpn Heart J |
pmid:10370402
|
McConnell SA and Amsden GW |
Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin. |
1999 |
Pharmacotherapy |
pmid:10212011
|
Dubois J and St-Pierre C |
In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species. |
1999 |
Diagn. Microbiol. Infect. Dis. |
pmid:10212753
|
Inoue M et al. |
[Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs]. |
1999 |
Jpn J Antibiot |
pmid:10396687
|
Son SW et al. |
The response of rosacea to eradication of Helicobacter pylori. |
1999 |
Br. J. Dermatol. |
pmid:10354058
|
Pilotto A et al. |
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients. |
1999 |
J. Gastroenterol. Hepatol. |
pmid:10355512
|
Jacoby EB and Porter KB |
Helicobacter pylori infection and persistent hyperemesis gravidarum. |
1999 |
Am J Perinatol |
pmid:10355915
|
Fost DA et al. |
Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy. |
1999 |
J. Allergy Clin. Immunol. |
pmid:10359882
|
Bhasin DK et al. |
Helicobacter pylori eradication: comparison of three treatment regimens in India. |
1999 |
J. Clin. Gastroenterol. |
pmid:10372934
|
Behrens R et al. |
Dual versus triple therapy of Helicobacter pylori infection: results of a multicentre trial. |
1999 |
Arch. Dis. Child. |
pmid:10373140
|
Masa K et al. |
Effect of clarithromycin and other macrolides on the sulfoxidation and 5-hydroxylation of lansoprazole in dogs. |
1999 |
Biol. Pharm. Bull. |
pmid:10375172
|
Bamford JT et al. |
Effect of treatment of Helicobacter pylori infection on rosacea. |
1999 |
Arch Dermatol |
pmid:10376693
|
Delle Cave M et al. |
Seven days of ranitidine bismuth citrate plus two antimicrobials for Helicobacter pylori eradication. |
1999 |
Ital J Gastroenterol Hepatol |
pmid:10379492
|
Schubert ML |
H. pylori and nonulcer dyspepsia: not guilty as charged. |
1999 |
Gastroenterology |
pmid:10381939
|
Yonemochi E et al. |
Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying. |
1999 |
Eur J Pharm Sci |
pmid:9971917
|
Piquette RK |
Torsade de pointes induced by cisapride/clarithromycin interaction. |
1999 |
Ann Pharmacother |
pmid:9972380
|
Principi N and Esposito S |
Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients. |
1999 |
Drug Saf |
pmid:9935275
|
Burgess DS et al. |
A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance. |
1999 |
Ann Pharmacother |
pmid:10630825
|
Allevi P et al. |
A new convenient transformation of erythromycin A into clarithromycin. |
1999 |
Bioorg. Med. Chem. |
pmid:10658579
|
Kamochi H et al. |
Clarithromycin associated with torsades de pointes. |
1999 |
Jpn. Circ. J. |
pmid:10943628
|
Smoot DT et al. |
Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori. |
1999 |
Am. J. Gastroenterol. |
pmid:10201463
|
Laine L et al. |
Once-daily therapy for H. pylori infection: a randomized comparison of four regimens. |
1999 |
Am. J. Gastroenterol. |
pmid:10201465
|
Khan AA et al. |
Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10221415
|
Periti P and Mazzei T |
Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen. |
1999 |
J Chemother |
pmid:10078776
|
Sunazuka T et al. |
Effects of erythromycin and its derivatives on interleukin-8 release by human bronchial epithelial cell line BEAS-2B cells. |
1999 |
J. Antibiot. |
pmid:10092202
|
Garey KW et al. |
Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223928
|